Question 1

What is the Starter Panel?

Accepted Answer

The Starter Panel is a focused blood panel designed to evaluate key inflammatory and immune patterns that may be relevant in mold exposure assessments. It includes 3 core biomarkers: TGF-β1 (inflammatory signaling marker), MMP-9 (immune response and inflammation related marker), and MSH (hormone signaling marker commonly reviewed in chronic symptom patterns).

Question 2

Do I need a clinician visit first?

Accepted Answer

No separate clinician visit is required before ordering. MoldRx provides a clinician-reviewed requisition as part of the process. If you prefer a consultation first, you can book one through the care program.

Question 3

How do blood draws work in Canada?

Accepted Answer

After your order is processed and requisition issued, you will receive instructions to book at a participating Canadian laboratory. Most patients can complete their blood draw within a few days of receiving instructions.

Question 4

What if I already have recent labs?

Accepted Answer

If you have recent labs that include relevant markers, you may be able to share those with a clinician for review. Contact MoldRx to discuss your situation.

Question 5

How long does it take to get results?

Accepted Answer

Results are typically available within two to three weeks after your blood draw, depending on laboratory processing times.

Question 6

What provinces are supported?

Accepted Answer

Availability varies by province. You will confirm eligibility during the intake process based on your location.

Question 7

Can these markers diagnose mold illness?

Accepted Answer

These biomarkers provide data points that may help guide clinical assessment, but they are not diagnostic on their own. Results should be reviewed with a qualified healthcare provider who can interpret them in the context of your symptoms and history. These markers do not diagnose mold illness on their own — they help you and your clinician understand the body's current state.

Question 8

What happens after I get my results?

Accepted Answer

You will receive your results with clear explanations of what each marker may indicate. If further evaluation is appropriate, MoldRx can guide you on next steps, whether that is additional testing or consultation with a clinician through the care program.

Question 9

Is the Starter Panel right for me?

Accepted Answer

The Starter Panel is designed as an initial assessment for individuals who may have been exposed to mold or water-damaged environments and are experiencing unexplained symptoms. The panel is ideal for Canadians seeking structured, non-alarmist insight into inflammation and immune patterns after suspected mold exposure, water damage, or persistent symptoms.

Question 10

What makes MoldRx different from other testing services?

Accepted Answer

MoldRx is built specifically for Canadian households, integrates both environmental and health biomarker testing, includes clinician requisitions for blood panels, and avoids fear-based messaging in favor of calm, actionable clarity. The service prioritizes privacy, provides secure portal delivery of results, and emphasizes evidence-cited education with responsible boundaries.

Question 11

Is MoldRx a diagnostic service?

Accepted Answer

No. MoldRx is educational and provides decision-support testing only. It is not medical advice, not for emergencies, and results should be reviewed with a qualified clinician. MoldRx emphasizes responsible boundaries and evidence-cited education.

Question 12

What is included in the Starter Panel?

Accepted Answer

The Starter Panel includes: clinician-reviewed requisition for 3 core biomarkers, blood draw at a participating Canadian lab, guided results with clear interpretation, next-step recommendations based on your markers, secure portal access to view and share results, and the option to add more markers or upgrade later.

Question 13

How much does the Starter Panel cost?

Accepted Answer

The Starter Panel costs $561.00 CAD.

Question 14

Why are these biomarkers important?

Accepted Answer

These biomarkers are commonly evaluated in clinical assessments of patients who have been exposed to damp or water-damaged buildings. Research suggests that exposure to indoor dampness and mold may be associated with respiratory symptoms and immune responses. The Starter Panel provides a focused initial evaluation of key inflammatory and hormonal markers that clinicians often review when assessing potential mold-related health concerns.